LB

Lotus BioScience Ventures

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

Lotus BioScience Ventures finances seed, early, and mid stage companies in the biotherapeutics industry.

Investor Profile

Lotus BioScience Ventures has made 7 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series D (57%)
  • Series B (29%)
  • Private Equity (14%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Clinical Trials
  • Medical Device
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lotus BioScience Ventures frequently co-invest with?

Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 3
SB
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 2
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 3
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 3
Alloy Ventures
North America, California, United States, Palo Alto
Co-Investments: 3
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2
GBS Ventures
Oceania, Victoria, Australia, Melbourne
Co-Investments: 3
Forward Ventures
North America, California, United States, San Diego
Co-Investments: 2
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2

Which angels does Lotus BioScience Ventures often collaborate with?

SP
Europe, Germany
Shared Deals: 1
FM
North America, United States
Shared Deals: 1
SH
North America, New Hampshire, United States, Center Harbor
Shared Deals: 1

What are some of recent deals done by Lotus BioScience Ventures?

Kalobios Pharmaceuticals, Inc.

South San Francisco, California, United States

KaloBios Pharmaceuticals is a biotechnology company that develops advancing medicines for patients.

Biotechnology
Series DSep 23, 2008
Amount Raised: $20,000,000
Humanigen

Burlingame, California, United States

Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series DSep 23, 2008
Amount Raised: $20,000,000
Nereus Pharmaceuticals

San Diego, California, United States

Nereus Pharmaceuticals engages in the discovery and development of therapeutics for the treatment of infectious diseases and inflammation.

BiotechnologyHealth CareMedical
Series DOct 19, 2005
Amount Raised: $42,600,000
Anadys Pharmaceuticals

San Diego, California, United States

Anadys Pharmaceuticals develops novel therapeutics for the treatment of chronic hepatitis C viral infections.

BiotechnologyHealth Care
Private EquityAug 11, 2005
Amount Raised: $71,300,000
Humanigen

Burlingame, California, United States

Humanigen is a biopharmaceutical company that focuses on developing human antibody therapeutics.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series BMar 16, 2005
Amount Raised: $20,000,000
Infinity Pharmaceuticals

Cambridge, Massachusetts, United States

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

BiopharmaBiotechnologyPharmaceutical
Series BJun 24, 2002
Amount Raised: $70,000,000
Dynavax Technologies

Berkeley, California, United States

Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.

BiopharmaBiotechnologyClinical TrialsHealth CareMedical Device
Series DApr 25, 2002
Amount Raised: $34,800,000